Healthy Business Strategies - Clean Production Action
Healthy Business Strategies - Clean Production Action
Healthy Business Strategies - Clean Production Action
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
is now a known PBT. It is highly persistent,<br />
bioaccumulates in the bodies of animals<br />
and is toxic — damaging animal growth and<br />
development (Washington State 2005). For<br />
these reasons the British government is acting<br />
to ban the use of PFOS (uK 2004).<br />
Implications for Public Health<br />
Scientists are divided over what the presence<br />
of persistent, bioaccumulative and toxic substances<br />
means for public health. A synthetic<br />
chemical in someone’s urine or breast milk<br />
does not automatically result in health effects<br />
— instead it’s an indicator of exposure. But<br />
their ubiquity doesn’t mean there is no effect<br />
either. It’s well known<br />
Toxics ignorance<br />
that humans are not<br />
creates risk: reputation exposed equally and<br />
risk, toxic tort risk that we vary in genetic<br />
and physical vulnerabili-<br />
and market risk.<br />
ties. Furthermore, most<br />
chemicals on the market have not been<br />
thoroughly tested for human safety. Moreover,<br />
scientists have yet to assess the risks of<br />
exposure to combinations of these chemicals.<br />
One thing scientists are finding is that the<br />
timing of the exposure can be as important<br />
as the amount of exposure. Specifically, new-<br />
“Babies aren’t supposed to be born pre-polluted.”<br />
— Jane Houlihan, Environmental Working Group<br />
borns, fetuses and infants are particularly<br />
vulnerable to even small chemical exposures<br />
during the critical moments of gestation and<br />
early development. Recent studies have measured<br />
this exposure — for example, a 2005<br />
u.S. study of umbilical cord blood from 10<br />
newborns found the newborns averaged 200<br />
contaminants, many of them carcinogens,<br />
developmental toxins and neurotoxins (EWG<br />
2005). Scientists worry that exposure in the<br />
womb could affect critical steps in fetal<br />
development.<br />
Table 3 details below the health effects and<br />
sources of exposure for a handful of chemicals<br />
and materials that have been targeted<br />
by many companies, including some of the<br />
six case study companies. The high hazard<br />
chemicals include heavy metals such as<br />
arsenic, cadmium, lead and mercury; phthalates;<br />
perfluorinated chemicals; brominated<br />
flame retardants; and azo dyes. PvC, which<br />
has significant life cycle concerns, is unique<br />
within the list because it is a material as<br />
opposed to a chemical.<br />
What about the U.s. Regulatory system?<br />
Some may wonder whether the u.S. regulatory<br />
system protects human health and the<br />
environment from chemical hazards such<br />
as PBTs. unfortunately, the u.S. regulatory<br />
safeguards for toxic chemicals are inadequate.<br />
Only a small fraction of the 81,600<br />
chemicals on the u.S. market have ever been<br />
screened for a single possible health effect<br />
such as cancer. This is because 76 percent of<br />
chemicals registered for use in the u.S. were<br />
“grandfathered” under the 1976 Toxics Substances<br />
Control Act — meaning chemical<br />
manufacturers were not required to disclose<br />
information on their toxicity. Today, these<br />
“1976 chemicals” constitute the majority<br />
of chemicals used by volume in the u.S.<br />
In 1998, the u.S. Environmental Protection<br />
healthy business strategies for transforming the toxic chemical economy